LATEST NEWS
We help you choose the right quality and regulatory actions at the right stage
The selection of appropriate quality and regulatory actions at the correct stage of product development is a critical determinant of success in regulated life science industries. Misalignment between ... ...more
Quality Culture ,Compliance
April 06, 2026•6 min read
Challenges of Early Stage Sponsors and Manufacturers for Medicines
Early stage sponsors and manufacturers of medicinal products operate within a complex and evolving environment where scientific innovation must be balanced with regulatory compliance and operational c... ...more
QMS ,Compliance
April 01, 2026•6 min read
CAR T-Cell for Cancer Cell Therapy – eQMS Support
The CAR T-cell therapy eQMS implementation project undertaken by Quality Systems Now demonstrated the critical role of integrated quality systems in supporting advanced therapeutic manufacturing envir... ...more
Quality Culture ,QMS
March 30, 2026•7 min read
Lab Notebooks, Shared Drives, eQMS — What’s “Good Enough”
By implementing structured, risk-based, and auditable recordkeeping practices, therapeutic goods manufacturers, testing laboratories, and biotechnology companies can confidently demonstrate that their... ...more
Compliance
March 24, 2026•5 min read
Data Integrity and Good Documentation Practices
Data integrity and good documentation practices form the backbone of compliance and scientific rigor in GxP-regulated industries. By adhering to principles such as ALCOA+, ensuring traceable and accur... ...more
Quality Culture ,Compliance
March 22, 2026•5 min read
Showing Maturity Without Overselling
Showing maturity without overselling is a strategic imperative for organisations operating under GxP and regulatory compliance frameworks. Evidence-based demonstration, transparent communication, incr... ...more
GMP
March 18, 2026•5 min read
Build Strong Foundations Before You Scale
Scaling in GxP-regulated environments is a complex and high-risk undertaking that requires a strong foundational framework. A robust Quality Management System, validated processes, reliable data pract... ...more
Quality Culture
March 16, 2026•6 min read
Transition to ISO17025 Accreditation
or laboratories operating in regulated industries, including biotechnology, therapeutic goods, and medical devices, achieving ISO17025 accreditation enhances credibility, supports regulatory complianc... ...more
ISO 17025
March 11, 2026•5 min read
From Lab Results to Defensible Evidence
Transforming laboratory results into defensible evidence requires rigorous adherence to quality systems, data integrity principles, and regulatory compliance standards. By implementing structured proc... ...more
Compliance
March 10, 2026•5 min read
Risk Management and ISO14971
ISO14971 provides a structured, scientifically rigorous framework for managing risk across the medical device lifecycle. Integration with ISO13485 quality systems ensures comprehensive coverage of des... ...more
ISO 14971
March 04, 2026•5 min read
ISO13485 Transition Support A Case Study
The transition to updated ISO13485 requirements represents a complex undertaking for medical device manufacturers, particularly when products involve both physical diagnostic components and software s... ...more
ISO13485 Certification
March 02, 2026•7 min read
Decision-Making Under Uncertainty
Decision-making under uncertainty is a defining challenge for therapeutic goods startups. Companies must determine when to validate, submit, or scale manufacturing while balancing quality requirements... ...more
Leadership Values ,Medtech
February 26, 2026•5 min read
TGA Compliance Principles 2026 and 2027
The TGA Compliance Principles 2026 and 2027 provide a structured, risk-based framework for monitoring, enforcing, and supporting compliance with the Therapeutic Goods Act 1989. ...more
Therapeutic Goods Administration ,Compliance
February 22, 2026•5 min read
A High-Level Guide to Electronic Records and Signatures
A high-level understanding of 21 CFR Part 11 enables companies to navigate the complexities of electronic data management effectively, demonstrating compliance and fostering trust with regulators, par... ...more
Procedures and Policies ,Leadership Values
February 18, 2026•5 min read
Data Integrity Fundamentals and ALCOA(+/++) Principles
By applying these scientific and regulatory standards consistently, organizations can foster a culture of accountability, reliability, and excellence—ensuring that every piece of data serves its inten... ...more
Quality Culture
February 15, 2026•6 min read
From Chaos to Control: Transform Regulatory Ambiguity into Market Strategy
By transforming chaos into control, businesses can leverage regulatory compliance as a tool for market differentiation, operational excellence, and sustainable growth ...more
Leadership Values ,Compliance
February 09, 2026•5 min read
A Case Study of Providing GMP Support to a Wholesaler of Radiopharmaceuticals
This case study demonstrates the critical importance of GMP support for wholesalers of radiopharmaceuticals. By partnering with Quality Systems Now, the client was able to implement comprehensive qual... ...more
Quality Training ,GMP
February 08, 2026•5 min read
QSN Isn’t Just External Support — It’s Capability Building That Stays With the Company
Investing in QSN’s capability-building approach transforms compliance from a temporary activity into a sustainable organisational strength, reinforcing quality culture, reducing risk, and enabling lon... ...more
QMS ,Compliance
February 04, 2026•5 min read
TGA Compliance Principles 2026–2027: A Proactive and Risk-Based Approach
The TGA Compliance Principles for 2026 and 2027 reflect a proactive, risk-based approach to safeguarding public health through the regulation of therapeutic goods. ...more
News
February 03, 2026•5 min read
Achieving Organizational Discipline Around Quality Records
Achieving organizational discipline around quality records is a scientific and systematic endeavor that extends across regulatory, operational, and cultural dimensions. ...more
Procedures and Policies ,Quality Culture
January 29, 2026•5 min read
From Design Controls to Clinical Evidence
From design controls to clinical evidence, the development of therapeutic goods is a continuous, interconnected process grounded in scientific discipline and regulatory compliance. ...more
Quality Culture
January 27, 2026•6 min read
Operational Knowledge Gaps
Quality Systems Now provides more than external support — it builds capability within startups, embedding regulatory, quality, and operational knowledge. By implementing structured QMS, regulatory pre... ...more
Leadership Values
January 22, 2026•4 min read
Funding & Investor Expectations
For therapeutic goods, biotechnology, and medical device startups, securing funding is not simply a matter of demonstrating innovative science. Investors require evidence of robust governance, clear r... ...more
News
January 20, 2026•4 min read
Establishing a Robust Quality Management System (QMS)
For therapeutic goods, biotechnology, and medical device startups, a robust QMS is essential for regulatory compliance, operational efficiency, and investor confidence. Early-stage companies often und... ...more
QMS
January 15, 2026•5 min read